|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 401/04 | |
| A61K 31/506 | |||
| C07D 403/04 | |||
| C07D 239/26 | |||
| A61P 25/00 |
| (11) | Number of the document | 3022189 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14742326.3 |
| Date of filing the European patent application | 2014-07-17 | |
| (97) | Date of publication of the European application | 2016-05-25 |
| (45) | Date of publication and mention of the grant of the patent | 2018-09-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/GB2014/052184 |
| Date | 2014-07-17 |
| (87) | Number | WO 2015/008073 |
| Date | 2015-01-22 |
| (30) | Number | Date | Country code |
| 201312800 | 2013-07-17 | GB |
| (72) |
CHRISTOPHER, John, Andrew, GB
CONGREVE, Miles, Stuart, GB
AVES, Sarah, Joanne, GB
TEHAN, Benjamin, Gerald, GB
|
| (73) |
Heptares Therapeutics Limited,
BioPark Broadwater Road, Welwyn Garden City, Hertfordshire AL7 3AX,
GB
|
| (54) | 4-(3-CYANOPHENYL)-6-PYRIDINYLPYRIMIDINE MGLU5 MODULATORS |
| 4-(3-CYANOPHENYL)-6-PYRIDINYLPYRIMIDINE MGLU5 MODULATORS |